LETITIA ANN HORRIGAN
Allopathic & Osteopathic Physicians|Internal Medicine WAKEFIELD, RI NPI 1760622617
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine RI Novo Nordisk AS All categories
General Payments — all program years on this page
$2,330.41
- Category: General Payments
- Program years: PY2018–2024
- Record count: 113
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,226.10 across 61 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,226.10 | 61 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $180.29 | 8 |
| ABBVIE INC. | $169.62 | 10 |
| GlaxoSmithKline, LLC. | $160.34 | 9 |
| Lilly USA, LLC | $129.45 | 6 |
| PFIZER INC. | $88.93 | 4 |
| Acerta Pharma LLC | $88.09 | 5 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $58.81 | 3 |
| Merck Sharp & Dohme Corporation | $56.87 | 3 |
| Astellas Pharma US Inc | $52.11 | 2 |
| Inspire Medical Systems, Inc. | $50.57 | 2 |
| Exact Sciences Corporation | $45.45 | 2 |
| Amgen Inc. | $25.38 | 1 |
| Abbott Laboratories | $24.23 | 1 |
| Sumitomo Pharma America, Inc. | $23.08 | 1 |
| Mylan Specialty L.P. | $22.69 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.14 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.34 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.71 | 1 |
By program year
Records — PY2024 (61)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.